INMEDBIO
InMEDBio develops safe, cost-effective and comprehensive wound care dressing.
INMEDBIO
Industry:
Health Care Medical
Address:
Charlottesville, Virginia, United States
Country:
United States
Website Url:
http://www.inmed.bio
Total Employee:
1+
Status:
Active
Contact:
(920) 279-4425
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro GStatic Google Static Content Google Cloud QUIC
Similar Organizations
Candela Medical
Candela Medical is aesthetic device company with a comprehensive product portfolio.
Theranostec
Theranostec is a developer of effective and safe anti-cancer therapies.
Vixiar Medical
Vixiar Medical develops non-invasive, cost-effective devices and systems for monitoring cardiopulmonary diseases.
Official Site Inspections
http://www.inmed.bio
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "InMEDBio"
Home | inmedbio
We are developing a safe, cost-effective and comprehensive wound care dressing to help prevent infections, and accelerate the healing of chronic wounds.See details»
About - InMed Pharmaceuticals
In parallel to InMed’s therapeutic development programs in skin and ocular diseases, InMed is developing a cannabinoid synthesis manufacturing system called IntegraSyn TM to produce cost-effective, pharmaceutical-grade, bio …See details»
InMed Pharmaceuticals - LinkedIn
InMed’s pipeline consists of three drug development programs in the treatment of Alzheimer’s, ocular and dermatological indications. Together with our subsidiary BayMedica, we are a …See details»
Inmedbio Llc - Drug pipelines, Patents, Clinical trials - Synapse
Explore Inmedbio Llc with its drug pipeline, therapeutic area, technology platform, .See details»
InMed Pharmaceuticals - LinkedIn
InMed Pharmaceuticals is a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors.See details»
InMed Pharmaceuticals Provides Business Update and Milestones …
Jan 16, 2024 InMed Pharmaceuticals is a global leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs. Together with …See details»
InMEDBio - Crunchbase Company Profile & Funding
InMEDBio develops safe, cost-effective and comprehensive wound care dressing.See details»
InMed Pharmaceuticals Increases Cannabinoid Yield to 5 g/L with ...
Jun 17, 2021 InMed’s cannabinoid yield of 5 g/L significantly exceeds currently reported industry yields. The Company has continued to make important steps to further optimize the …See details»
InMed Pharmaceuticals Inc. (NASDAQ: INM) Is ‘One to Watch’
Aug 3, 2021 InMed has a world class leadership team with a successful track record of drug development and commercialization; ... is a bio-med news and content distribution company …See details»
InMed Pharmaceuticals to Present at the 2021 BIO Digital …
Jun 9, 2021 VANCOUVER, British Columbia, June 09, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a clinical-stage company …See details»
InMed Pharmaceuticals Announces Commencement of Phase 2
Sep 30, 2021 About InMed: InMed Pharmaceuticals is a clinical-stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the …See details»
InMed Pharmaceuticals Inc. - Life Sciences British Columbia
Sep 30, 2021 InMed Pharmaceuticals Files Additional Patent Application for INM-901 in the Treatment of Neurodegenerative Conditions Including Alzheimer’s Disease. October 22, 2024. …See details»
InMed Pharmaceuticals to Present at the 2021 BIO Digital …
Jun 9, 2021 VANCOUVER, British Columbia, June 09, 2021 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a clinical-stage company …See details»
InMed Pharmaceuticals Achieves 2g/L Cannabinoid Yield with
Apr 26, 2021 About InMed: InMed Pharmaceuticals is a clinical-stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the …See details»
InMed Pharmaceuticals to Present at the BIO Investor Forum
Oct 18, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis... InMed …See details»
InMed Pharmaceuticals Signs Definitive Agreement to Acquire
Sep 13, 2021 InMed’s proprietary cannabinoid manufacturing process, IntegraSyn™, combined with BayMedica’s synthetic biology and chemical synthesis capabilities, will provide InMed with …See details»
Presentation of Inmed
Inmed is one of the most important neuroscience research center in France. It is a mixed structure Inserm – Aix-Marseille University, directed by Rosa Cossart. The main research topics are …See details»
InMed Pharmaceuticals Inc. (INM) Stock Price, News, Quote
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. It operates through two segments: InMed …See details»
Mediterranean Neurobiology Institute | NeuroMarseille
The Institute of Mediterranean Neurobiology (INMED) is a leading Neuroscience Centre affiliated to INSERM and Aix-Marseille University. INMED investigates the development and plasticity of …See details»